New breast scan could rival MRI for cancer detection
NCT ID NCT03495115
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new imaging technique called restriction spectrum imaging (RSI) to see if it can find breast cancer as well as standard breast MRI. About 460 women who were getting routine breast cancer screening took part. The goal was to compare how accurate RSI is versus conventional MRI for detecting cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
460 people
The number who actually took part.
- Started
-
Apr 2018
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Group 1 will consist of women who present for screening breast MRI: * Age \>= 18 * Female * Asymptomatic for breast disease * Presenting for routine breast cancer screening with MRI * Group 2 will consist of women who presented for a screening mammogram (2D or 3D tomosynthesis) AND who have had a biopsy recommended after diagnostic workup: * Age \>= 18 * Female * Asymptomatic for breast disease * Presenting for routine breast cancer screening with mammogram (2D or 3D tomosynthesis) and/or ultrasound * Biopsy recommended after subsequent diagnostic workup (BI-RADS 4 or 5) Radiologist Reader Participant Inclusion Criteria * Must have clinical experience in interpreting breast MRI. * Must have interpreted at least 10 breast MRI exams with RSI interpretation. Exclusion Criteria: -Known or suspected renal insufficiency, rendering the participant unable to safely receive intravenous contrast based on institutional clinical protocol. Renal insufficiency for the purposes of exclusion includes any of the following: * Failed Chokye questionnaire * Known history of end stage renal disease with EGFR\<30 mL/min/1.73m2 * Point of care (POC) measure of creatinine clearance (eGFR) prior to obtaining the MRI \<35. We will perform this POC test as needed per institutional policy for routine MRI if: (a) no creatinine result is available in the OMR within 30 days of the MRI exam, (b) the patient is \> 60 years old, or (c) the patient is on hydroxyurea. * History of adverse or allergic-like reaction to gadolinium MRI intravenous contrast, rendering the participant unable to safely receive intravenous contrast based on institutional clinical protocol. * Presence of MRI unsafe devices or objects which would make having an MRI unsafe, as per institutional clinical protocol. MRI unsafe devices or objects for the purposes of exclusion include but are not limited to certain intracranial aneurysm clips, cardiac pacemaker, and implantable defibrillator devices, metallic heart valve, or coronary artery stents, breast tissue expanders, bio or neurostimulators, pellets and bullets, ocular implants and devices, otologic and cochlear implants. Other devices or metallic objects may be deemed unsafe for MRI at the radiologist's discretion. * Unable to tolerate exam (i.e., secondary to untreatable claustrophobia, positioning constraints/unable to lie prone). * Body weight exceeds that allowable by the MRI table. * Breast biopsy or surgical intervention planned before the test RSI-MRI in this study. * Breast implants (silicone or saline). 8\. Nursing or thinks she may be or is pregnant, as gadolinium contrast-enhanced MRI is unsafe. We will perform a pregnancy test as needed per institutional policy for routine breast MRI. Per institutional clinical protocol, all females of childbearing potential who are uncertain if they are pregnant or think they are pregnant must have a blood test or urine study within 2 weeks prior to the MRI exam to rule out pregnancy. A female of childbearing potential is any woman, regardless of sexual orientation or prior tubal ligation, who: * Has not had a hysterectomy or bilateral oophorectomy OR * Has not been naturally post-menopausal for at least 2 years (i.e., has had menses at any time in the preceding 2 years Radiologist Reader Participant -None.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?